Please select your Region.

Please select your Region.

News & Topics

NEWLocal

Sep 11, 2025

Notice Regarding the Transfer of Manufacturing and Sales Rights for the In Vitro Diagnostic Reagent CinQ HbA1c

Local

Aug 19, 2025

The Lab 004 to be Presented in Expo 2025 Osaka, Kansai, Japan, Future Life Experience

Local

Jan 17, 2025

Four ARKRAY Group Companies Awarded the "PRIDE Index 2024 Gold Prize" for a Second Consecutive Year

Local

Jan 06, 2025

Summary of the New Year's Remarks for 2025

Local

Nov 25, 2024

Release of New Maintenance Contract Plan with Included Calibration Service for the Standard Osmotic Pressure Analyzer Product Model

Local

Nov 13, 2024

Pancreatitis Monitoring Made Possible with Vcheck V200
With Newly Added cPL (Canine) and fPL (Feline) Testing Reagents
Contributing to Quick Diagnosis in Veterinary Clinics

Global

Oct 09, 2024

Upcoming Webinar: The updated EFLM European Urinalysis guideline: particles in the picture!

Local

Aug 28, 2024

A Study for the Development of a Pancreatic Cancer Diagnostic Method Using miRNA in Blood
Comprehensive Analysis of miRNA in Blood can Discriminate the Development of Pancreatic Cancer with High Accuracy

Local

Mar 22, 2024

Contributing to Reducing Manual Tasks Before and After Measurement for Streamlined Testing Operations
ARKRAY Releases a New Model of Glucose (Blood Glucose) Measurement Instrument,
Equipped with an Automatic Rotating Sample Barcode Reading Function

Local

Jan 29, 2024

Detecting Three Types of Antigens
in Just Five Minutes
Launching the SARS-CoV-2/Flu (Types A/B)
Diagnostic Kit
Helping Reduce Bottlenecking in Medical Settings by
Shortening Test Times

Local

Dec 18, 2023

Four ARKRAY Group Companies Awarded the "PRIDE Index 2023 Gold Prize

Local

Nov 13, 2023

Contributing to Rapid Diagnosis of Hypothyroidism in Dogs Addition of TSH Testing Reagent to the Vcheck V200 Immunoassay Measurement Device

Local

Sep 15, 2023

"SillHa" has Evolved!

New service launched for the salivary testing instrument that "visualizes the oral environment"
Enabling more convincing feedback from dentists to patients

Local

Aug 03, 2023

"Quiet and accurate" measurement with its unique measurement method
Model change of a long-selling osmometer
Enhancement of accuracy control functions required for ISO15189

Local

Jul 28, 2023

For utilization in detecting side effects of the novel coronavirus and anti-cancer drugs
ARKRAY to start sales of fully automated gene analysis instruments
Completes sample pre-treatment, analysis, and determination on a single unit

Local

Apr 13, 2023

New Release of Protein Analyzer "The Lab 002" Rapid Measurement of Three Types of Inflammatory Proteins (CRP/ α1-AGP/Hp)

Local

Apr 05, 2023

Addition of SDMA Testing Reagent to"Vcheck V200", Immunoassay Meas. Device Dedicated to Cats and Dogs Effective for early detection of kidney disease through in-hospital examinations

Local

Jan 04, 2023

Summary of New Year Remarks for 2023

Local

Nov 22, 2022

ARKRAY Awarded the "PRIDE Index 2022 Gold Prize" for the Second Year Running
Efforts for LGBTQ measures in the workplace is recognized.

Global

Feb 16, 2022

Launch of the "ARKRAY 4U" support program for startup companies in the healthcare industry

NEWLocal

Sep 11, 2025

Notice Regarding the Transfer of Manufacturing and Sales Rights for the In Vitro Diagnostic Reagent CinQ HbA1c

Local

Aug 19, 2025

The Lab 004 to be Presented in Expo 2025 Osaka, Kansai, Japan, Future Life Experience

Local

Jan 17, 2025

Four ARKRAY Group Companies Awarded the "PRIDE Index 2024 Gold Prize" for a Second Consecutive Year

Local

Jan 06, 2025

Summary of the New Year's Remarks for 2025

Local

Nov 25, 2024

Release of New Maintenance Contract Plan with Included Calibration Service for the Standard Osmotic Pressure Analyzer Product Model

Local

Nov 13, 2024

Pancreatitis Monitoring Made Possible with Vcheck V200
With Newly Added cPL (Canine) and fPL (Feline) Testing Reagents
Contributing to Quick Diagnosis in Veterinary Clinics

Local

Aug 28, 2024

A Study for the Development of a Pancreatic Cancer Diagnostic Method Using miRNA in Blood
Comprehensive Analysis of miRNA in Blood can Discriminate the Development of Pancreatic Cancer with High Accuracy

Local

Mar 22, 2024

Contributing to Reducing Manual Tasks Before and After Measurement for Streamlined Testing Operations
ARKRAY Releases a New Model of Glucose (Blood Glucose) Measurement Instrument,
Equipped with an Automatic Rotating Sample Barcode Reading Function

Local

Jan 29, 2024

Detecting Three Types of Antigens
in Just Five Minutes
Launching the SARS-CoV-2/Flu (Types A/B)
Diagnostic Kit
Helping Reduce Bottlenecking in Medical Settings by
Shortening Test Times

Local

Dec 18, 2023

Four ARKRAY Group Companies Awarded the "PRIDE Index 2023 Gold Prize

Local

Nov 13, 2023

Contributing to Rapid Diagnosis of Hypothyroidism in Dogs Addition of TSH Testing Reagent to the Vcheck V200 Immunoassay Measurement Device

Local

Sep 15, 2023

"SillHa" has Evolved!

New service launched for the salivary testing instrument that "visualizes the oral environment"
Enabling more convincing feedback from dentists to patients

Local

Aug 03, 2023

"Quiet and accurate" measurement with its unique measurement method
Model change of a long-selling osmometer
Enhancement of accuracy control functions required for ISO15189

Local

Jul 28, 2023

For utilization in detecting side effects of the novel coronavirus and anti-cancer drugs
ARKRAY to start sales of fully automated gene analysis instruments
Completes sample pre-treatment, analysis, and determination on a single unit

Local

Apr 13, 2023

New Release of Protein Analyzer "The Lab 002" Rapid Measurement of Three Types of Inflammatory Proteins (CRP/ α1-AGP/Hp)

Local

Apr 05, 2023

Addition of SDMA Testing Reagent to"Vcheck V200", Immunoassay Meas. Device Dedicated to Cats and Dogs Effective for early detection of kidney disease through in-hospital examinations

Local

Jan 04, 2023

Summary of New Year Remarks for 2023

Local

Nov 22, 2022

ARKRAY Awarded the "PRIDE Index 2022 Gold Prize" for the Second Year Running
Efforts for LGBTQ measures in the workplace is recognized.